bs) with
varicose veins
(GSV)

EVLA (n ¼ 125);
RFA (n ¼ 125);
HL&S
(n ¼ 125)

UGFS, with
physiciancompounded
foam (3%
polidocanol);
n ¼ 125)

At 5 years, all treatment
modalities were
efﬁcacious and
resulted in similar
improvement in